Cyclosporine enhances liver regeneration: The role of hepatocyte MHC expression and PGE2 - A study relevant to graft immunogenicity

European Journal of Medical Research

Volumn 13, Issue 4, 2008, Pages 154-162

  Fouzas, Ioannis ^a,b   Daoudaki, M ^b   Sotiropoulos, G C ^b   Vrochides, D ^a   Papanikolaou, V ^a   Imvrios, G ^a   Sgourakis, G ^b   Molmenti, E P ^b   Vavatsi, N ^a   Thalhammer, T ^a   Takoudas, D ^a   Broelsch, C E ^b  

^a ARISTOTLE UNIVERSITY MEDICAL SCHOOL   (Greece)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Cyclosporine; E2; Flow cytometry; Hepatectomy; Hepatocyte; Immunogenicity: Major histocompatibility complex; Liver regeneration; Prostaglandin; Rats; SC 19220

Indexed keywords

1 ACETYL 2 (8 CHLORO 10,11 DIHYDRODIBENZ[B,F][1,4]OXAZEPINE 10 CARBONYL)HYDRAZINE; CYCLOSPORIN; DNA; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; DRUG MECHANISM; FLOW CYTOMETRY; HISTOCOMPATIBILITY; IMMUNOGENICITY; LIVER CELL; LIVER REGENERATION; LIVER TRANSPLANTATION; MALE; NONHUMAN; PARTIAL HEPATECTOMY; PROSTAGLANDIN SYNTHESIS; RAT;

ANIMALS; CELL DIVISION; CYCLOSPORINE; DIBENZ(B,F)(1,4)OXAZEPINE-10(11H)-CARBOXYLIC ACID, 8-CHLORO-, 2-ACETYLHYDRAZIDE; DINOPROSTONE; DNA; FLOW CYTOMETRY; HEPATECTOMY; HEPATOCYTES; IMMUNOSUPPRESSIVE AGENTS; LIVER REGENERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; PROSTAGLANDIN ANTAGONISTS; RATS; RATS, WISTAR; RECEPTORS, PROSTAGLANDIN E;

EID: 43849113231     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Olthoff KM. Molecular pathways of regeneration and repair after liver transplantation. World J Surg 2002;26 (7):831-837.
2. Higgins GM, Anderson RM. Experimental pathology of the liver. I. Restoration of the liver of the white rat following partial surgical removal. Arc Pathol 1931;12:186-202.
3. Francavilla A, Zeng Q, Polimeno L, Carr BI, Sun D, Porter KA, Van Thiel DH, Starzl TE. Small-for-size liver transplanted into larger recipient: a model of hepatic regeneration. Hepatology. 1994 Jan;19(1):210-6.
4. Fausto N. Liver regeneration: from laboratory to clinic. Liver Transpl. 2001 Oct;7(10):835-44.
5. Francavilla A, Barone M, Todo S, Zeng Q, Porter KA, Starzl TE. Augmentation of rat liver regeneration by FK 506 compared with cyclosporin. Lancet. 1989 Nov 25;2(8674):1248-9.
6. Yoshimura S, Kamada N. Effect of cyclosporine A on liver regeneration following partial hepatectomy in the mouse. Transplant Proc. 1989 Feb;21 (1 Pt 1):911-2.
7. Morii Y, Kawano K, Kim YI, Aramaki M, Yoshida T, Kitano S. Augmentative effect of cyclosporin A on rat liver regeneration: influence on hepatocyte growth factor and transforming growth factor-beta. Eur Surg Res. 1999;31(5):399-405.
8. Dahmen U, Gu Y, Shen K, Dirsch O, Li J, Fan L, Broelsch C. Onset of liver regeneration after subtotal resection is inhibited by the use of new immunosuppressive drugs. Transplant Proc. 2002 Sep;34(6):2312-3.
9. Kirimlioglu H, Kirimlioglu V, Yilmaz S, Coban S, Turkmen E, Ara C. Liver pathology and cell proliferation after drugs following partial hepatectomy in rats. Transplant Proc. 2006 Mar;38(2):622-6.
10. Grant D, Black R, Zhong R, Wall W, Stiller C, Duff J. The effect of cyclosporine on liver regeneration. Transplant Proc. 1988 jun;20(3 Suppl 3):877-9.
11. Shinohara H, Shimada M, Ogasawara T, Morine Y, Ikemoto T, Imura S, Fujii M. Pharmacokinetics of cyclosporine A after massive hepatectomy: a hint for small-for-size graft in living donor liver transplantation.Dig Dis Sci. 2007 Oct;52(10):2490-6.
12. Kim YI, Caine RY, Nagasue N. Cyclosporin stimulates proliferation of the liver cells after partial hepatectomy in rats. Surg Gynecol Obstet. 1988 Apr;166(4):317-22
13. Tanaka N, Yamamoto H, Tatemoto A, Urabe T, Orita K. Regulation of liver regeneration by interleukin-2 and its inhibitors: cyclosporine A and FK 506. Int J Immunopharmacol. 1993 Feb;15(2):211-8.
14. Schreiber LS, Crabtree RG. The mechanism of action of cyclosporin A and FK506. Immunol Today. 1992 Apr;13(4):136-42.
15. Ito H, Ando K, Nakayama T, Taniguchi M, Ezaki T, Saito K, Takemura M, Sekikawa K, Imawari M, Seishima M, Moriwaki H. Role of Valpha 14 NKT cells in the development of impaired liver regeneration in vivo. Hepatology. 2003 Nov;38(5):1116-24.
16. Sun R, Gao B. Negative regulation of liver regeneration by innate immunity (natural killer cells/interferon-gamma). Gastroenterology. 2004 Nov;127(5):1525-39.
17. Francavilla A, Starzl TE, Barone M, Zeng QH, Porter KA, Zeevi A, Markus PM, van don Brink MR, Todo S. Studies on mechanisms of augmentation of liver regeneration by cyclosporine and FK 506. Hepatology. 1991 Jul;14(1):140-3.
18. Khanna A, Li B, Stenzel KH, Suthanthiran M. Regulation of new DNA synthesis in mammalian cells by cyclosporine. Demonstration of a transforming growth factor beta-dependent mechanism of inhibition of cell growth. Transplantation. 1994 Feb 27;57(4):577-82
19. Russell WE, Coffey RJ, Ouellette AJ, Moses HL. Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in t he rat. Proc Natl Acad Sci U S A, 1988 Jul;85(14):5126-30.
20. Strain AJ, Frazer A, Hill DJ, Milner RD. Transforming growth factor beta inhibits DNA synthesis in hepatocytes isolated from normal and regenerating rat liver. Biochem Biophys Res Commun. 1987 May 29;145(1):436-42.
21. Whisler RL, Lindsey JA, Proctor KV, Newhouse YG, Cornwell DG. The impaired ability of human monocytes to stimulate autologous and allogeneic mixed lymphocyte reactions after exposure to cyclosporine. Associated alterations of HLA-DR expression and physical characteristics of monocytes. Transplantation. 1985 Jul;40(1):57-61.
22. Lee YR, Yang IH, Lee YH, Im SA, Song S, Li H, Han K, Kim K, Eo SK, Lee CK. Cyclosporin A and tacrolimus, but not rapamycin, inhibit MHC-restricted antigen presentation pathways in dendritic cells. Blood. 2005 May 15;105(10):3951-5.
23. Pistorius A, Willershausen B, Callaway A.Effects of selected immunosuppressive drugs on prostaglandin release, protein synthesis and cell proliferation in human gingival fibroblasts and on the growth of plaque bacteria. Eur J Med Res. 2003 Jan 28;8(1):25-32.
24. Li G, Harton JA, Zhu X, Ting JP. Downregulation of CIITA function by protein kinase a (PKA)-mediated phosphorylation: mechanism of prostaglandin E, cyclic AMP, and PKA inhibition of class II major histocompatibility complex expression in monocytic lines. Mol Cell Biol. 2001 Jul;21(14):4626-35
25. 2. Immunology. 2006 Jul;118(3):343-52.
26. Jiang X, Gregory SH, Wing EJ. Hepatocytes can serve as accessory cells in the response of immune T lymphocytes to heat-killed listeria monocytogenes. Infect Immun. 1995 Mar;63(3):926-33.
27. Herkel J, Jagemann B, Wiegard C, Lazaro JF, Lueth S, Kanzler S, Blessing M, Schmitt E, Lohse AW. MHC class II - expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocytes. Hepatology. 2003 May;37(5):1079-85
28. Flye MW, Yu S. Augmentation of cell-mediated cytotoxicity following 50% partial hepatectomy. Transplantation. 1990 Mar;49(3):581-7.
29. Itoh H, Abo T, Sugawara S, Kanno A, Kumagai K. Age-related variation in the proportion and activity of murine liver natural killer cells and their cytotoxicity against regenerating hepatocytes. J Immunol. 1988 Jul 1;141(1):315-23.
30. 2 and rat liver regeneration. Gastroenterology. 1993 Aug; 105(2):495-9.
31. Rudnick DA, Perlmutter DH, Muglia LJ. Prostaglandins are required for CREB activation and cellular proliferation during liver regeneration. Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8885-90.
32. Schoen Smith JM, Lautt WW. The role of prostaglandins in triggering the liver regeneration cascade. Nitric Oxide. 2005 Sep;13(2):111-7.
33. Adachi T, Nakashima S, Saji S, Nakamura T, Nozawa Y. Roles of prostaglandin production and mitogen-activated protein kinase activation in hepatocyte growth factor-mediated rat hepatocyte proliferation. Hepatology. 1995 Jun;21(6):1668-74.
34. Refsnes M, Dajani OF, Sandnes D, Thoresen GH, Rottingen JA, Iversen JG, Christoffersen T. On the mechanisms of the growth-promoting effect of prostaglandins in hepatocytes: the relationship between stimulation of DNA synthesis and signaling mediated by adenylyl cyclase and phosphoinositide-specific phospholipase C. J Cell Physiol. 1995 Sep;164(3):465-73.
35. 3 subtype. Am J Physiol. 1997 Mar;272(3 Pt 1):G597-604.
36. 1) receptor agonist-induced DNA synthesis and proliferation in primary cultures of adult rat hepatocytes: The involvement of TGFα. Endocrinology. 2001 Oct;142(10): 4428-40.
37. Matsumoto K, Okazaki H, Nakamura T. Novel functions of prostaglandins as inducers of gene expression of HGF and putative mediators of tissue regeneration. J Biochem (Tokyo). 1995 Feb;117(2):458-64.
38. Michalopoulos GK. Liver regeneration. J Cell Physiol. 2007 Nov;213(2):286-300.
39. Sugimoto Y, Narumiya S. Prostaglandin E receptors. J Biol Chem. 2007 Apr 20;282(16):11613-7.
40. Fennekohl A, Schieferdecker HL, Jungermann K, Püschel CP. Differential expression of prostanoid receptors in hepatocytes, kupffer cells, sinusoidal endothelial cells and stellate cells of rat liver. J Hepatol. 1999 Jan;30(1):38-47.
41. 1, inhibits osteoclastogenesis by RANKL. J Bone Miner Res. 2005 Jan;20(1):15-22.
42. 1 antagonist may inhibit central interleukin-1b-induced fever in rats. Am J Physiol. 1998 Dec;275(6 Pt 2):R1762-5.
43. Alzet osmotic minipumps. Technical information manual. Alza, Scientific products, www.alzet.com
44. Graf J, Peterlik M. Ouabain-mediated sodium uptake and bile formation by isolated perfused rat liver. Am J Physiol. 1976 Apr;230(4):876-85.
45. Alpini G, Phillips JO, Vroman B, LaRusso NF. Recent advances in the isolation of liver cells. Hepatology. 1994 Aug;20(2):494-514.
46. Andres D, Diez-Fernandez C, Zaragoza A, Alvarez A, Cascales M. Induction of cell proliferation by cyclosporine A in primary cultures of rat hepatocytes. Biochem Pharmacol. 2001 Feb 15;61(4):427-35.
47. Lilja H, Blanc P, Demetriou AA, Rozga J. Response of cultured fetal and adult rat hepatocytes to growth factors and cyclosporine. Cell Transplant. 1998 May-Jun;7(3):257-66.
48. Román ID, Rodríguez-Henche N, Fueyo JA, Zueco JA, Menor C, Prieto JC, Guijarro LG. Cyclosporin A induces apoptosis in rat hepatocytes in culture. Arch Toxicol. 1998 Sep;72(9):559-65.
49. Kim YI, Kobayashi M, Egashira T, Kawano K, Morimoto A, Kai T, Shimada T. Augmentation of hepatocyte proliferation by immunosuppressant pretherapy is associated with up-regulation of malondialdehyde production. Res Exp Med (Berl). 1993;193(5):337-45.
50. 2 production in human gingival fibroblasts challenged with tumor necrosis factor alpha in vitro. J Oral Pathol Med. 1997 Jan; 26(1):11-6.
51. Sato Y, Tsukada K, Matsumoto Y, Abo T. Interferon-gamma inhibits liver regeneration by stimulating major histocompatibility complex class II antigen expression by regenerating liver. Hepatology. 1993 Aug;18(2):340-6.
52. Jonji S, Radosevi-Stasi B, Cuk M, Jonji N. Class II antigen induction in the regenerating liver of rats after partial hepatectomy. Transplantation. 1987 Jul;44(1):165-8.
53. Senaldi G, Lobo-Yeo A, Mowat AP, Mieli-Vergani G, Vergani D. Class I and class II major histocompatibility complex antigens on hepatocytes: importance of the method of detection and expression in histologically normal and diseased livers. J Clin Pathol. 1991 Feb;44(2): 107-14.
54. Lai HS, Chen WJ, Chen KM. Changes in T-lymphocyte subpopulations and serum lymphokine concentrations after partial hepatectomy in rats. Nutrition. 1996 Oct; 12(10):700-5.
55. Ivashkiv LB, Ayres A, Glimcher LH. Inhibition of IFN-gamma induction of class II MHC genes by cAMP and prostaglandins. Immunopharmacology. 1994 Jan-Feb;27(1):67-77.
56. 4 subtypes regulate activation and differentiation of mouse B lymphocytes to IgE-secreting cells. Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):10978-83.
57. Miyahara S, Yokomuro K, Takahashi H, Kimura Y. Regeneration and the immune system. I. In vitro and in vivo activation of lymphocytes by liver regeneration and the role of Kupffer cells in stimulation. Eur J Immunol. 1983 Nov;13(11):878-83.
58. Yang ZF, Ho DW, Chu AC, Wang YQ, Fan ST. Linking inflammation to acute rejection in small-for-size liver allografts: the potential role of early macrophage activation. Am J Transplant. 2004 Feb;4(2):196-209.
59. Demetris AJ, Kelly DM, Eghtesad B, Fontes P, Wallis Marsh J, Tom K, Tan HP, Shaw-Stiffel T, Boig L, Novelli P, Planinsic R, Fung JJ, Marcos A. Pathophysiologic Observations and Histopathologic Recognition of the Portal Hyperperfusion or Small-for-Size Syndrome. Am J Surg Pathol. 2006 Aug;30(8):986-93.
60. Bertolino P, Trescol-Biemont MC, Rabourdin-Combe C. Hepatocytes induce functional activation of naive CD8+ T lymphocytes but fail to promote survival. Eur J Immunol. 1998 Jan;28(1):221-36.
61. Mele TS, Kneteman NM, Zhu LF, Ramassar V, Urmson J, Halloran B, Churchill TA, Jewell L, Kane K, Halloran PF. IFN-gamma is an absolute requirement for spontaneous acceptance of liver allografts. Am J Transplant. 2003 Aug;3(8):942-51.
62. Tanaka K, Shimada H, Matsuo K, Ueda M, Endo I, Togo S. Remnant liver regeneration after two-stage hepatectomy for multiple bilobar colorectal metastases. Eur J Surg Oncol. 2007 Apr;33(3):329-35.